Clinical Trial Update: Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine plus cisplatin in metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED